Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001852880-25-000003
Filing Date
2025-06-30
Accepted
2025-06-30 18:18:43
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751321917.html 4  
1 FORM 4 wk-form4_1751321917.xml 4 3839
  Complete submission text file 0001852880-25-000003.txt   5265
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Sutherland Everett Rand (Reporting) CIK: 0001852880 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38210 | Film No.: 251093616